ArticleFrontiers in immunology2022

Efficacy and safety of camrelizumab in combination with neoadjuvant chemotherapy for ESCC and its impact on esophagectomy.

Yujin Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.